Vertex Pharmaceuticals, Inc. (VRTX) Tops Q4 EPS by 16c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $528.19 +2.45%
Financial Fact:
Net loss attributable to Vertex: -38.84M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Net loss attributable to Vertex: -38.84M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q4 EPS of $0.86, $0.16 better than the analyst estimate of $0.70. Revenue for the quarter came in at $563.3 million versus the consensus estimate of $518.36 million.
For earnings history and earnings-related data on Vertex Pharmaceuticals, Inc. (VRTX) click here.
For earnings history and earnings-related data on Vertex Pharmaceuticals, Inc. (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
